SL PHARM released its first-quarter performance, with a net profit attributable to the parent company of 45.9684 million yuan, a year-on-year decrease of 34.46%
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, SL PHARM released its Q1 2025 report. In the first quarter, the company achieved operating revenue of 169 million yuan, a year-on-year decrease of 31.10%. The net profit attributable to shareholders of the listed company was 45.9684 million yuan, a year-on-year decrease of 34.46%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 21.1418 million yuan, a year-on-year decrease of 79.19%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments